Page last updated: 2024-11-06

denzimol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

denzimol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID53626
CHEMBL ID41849
SCHEMBL ID2110767
MeSH IDM0098459

Synonyms (25)

Synonym
denzimol
rec-151533
n-(beta-(4-(beta-phenylethyl)phenyl)-beta-hydroxyethyl)imidazole
denzimolo [latin]
rec 15-1533
ccris 7525
1h-imidazole-1-ethanol, alpha-(4-(2-phenylethyl)phenyl)-
einecs 277-642-5
denzimol [inn]
(+-)-alpha-(p-phenethylphenyl)imidazole-1-ethanol
CHEMBL41849
9c78o7jath ,
unii-9c78o7jath
denzimolo
73931-96-1
(+-)-2-(1-imidazolyl)-1-(4-phenethylphenyl)ethanol
(+/-)-.alpha.-(p-phenethylphenyl)imidazole-1-ethanol
SCHEMBL2110767
2-imidazol-1-yl-1-[4-(2-phenylethyl)phenyl]ethanol
chloroaceticacidvinylester
alpha-[4-(2-phenylethyl)phenyl]-1h-imidazole-1-ethanol
Q27272351
-[4-(2-phenylethyl)phenyl]-1h-imidazole-1-ethanol
alpha-(4-(2-phenylethyl)phenyl)-1h-imidazole-1-ethanol
DTXSID70868275

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Denzimol pretreatment significantly increased plasma and brain concentrations of the benzodiazepine, consistent with reduced total clearance."( Effect of the anticonvulsant denzimol on the disposition of diazepam in the rat.
Caccia, S; Conforti, L; Conti, I, 1986
)
1.28

Dosage Studied

ExcerptRelevanceReference
" The following overall results were obtained: the acute oral toxicity in mice and rats is of low order; in the chronic oral studies denzimol was generally well tolerated when given to rats for 13 and 26 weeks and to dogs for 52 weeks at different dosage levels."( Denzimol, a new anticonvulsant drug. III. Toxicological evaluation.
Barbadoro, E; Graziani, G; Testa, R, 1983
)
1.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1312146Clearance in human2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives.
AID122338Compound was tested for time to peak anticonvulsant effect (TPE)1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
AID112798Compound was tested for effective dose in mice by horizontal screen assay (administered orally); No effect at highest dose of 100 mg/kg1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
AID112809Compound was tested for effective dose in mice by pentylenetetrazole assay (administered subcutaneously); Bell shaped dose response curve1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
AID112804Effective dose in mice by maximal electroshock assay, administered orally1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
AID1312147Volume of distribution in human2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives.
AID1312148Half life in human2016Bioorganic & medicinal chemistry, 09-15, Volume: 24, Issue:18
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives.
AID119413Potentiation of hexobarbital-induced sleeping time in mice1986Journal of medicinal chemistry, Sep, Volume: 29, Issue:9
Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199025 (96.15)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (3.85)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (7.69%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]